Precipio, Inc. PRPO
18.62 USD +0.73 (+4.08%)
At closeNov 3, 2026, 4:00 PM EST
18.62 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
18.00 Day range 19.26
17.79 52-week range 33.63
- YTD
- -18.97%
- 1 year
- -6.76%
- Market cap
- 33.33M
- Revenue (ttm)
- 16.72M
- Profit margin
- -22.90%
- EPS (ttm)
- -0.64
- Shares out
- 1.48M
- Forward P/E
- 13.34
- YTD return
- -18.97%
- 1-year return
- -6.76%
- Volume
- 17.97K
- Avg volume
- 104.01K
- Open
- 18.35
- Previous close
- 17.89
- Day's range
- 18.00 – 19.26
- 52-week range
- 17.79 – 33.63
- Beta
- 1.42
6M -11.08 (-37.31%)
Key statistics
- Enterprise value
- 9.10M
- PEG ratio
- 0.00
- Price / sales
- 0.46
- Price / book
- 0.51
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 25.70%
- Free cash flow
- -894.75K
- Total cash
- 1.28M
- Total debt
- 1.17M
- Return on equity
- -29.22%
- Short % of float
- 0.35%
- 50-day average
- 6.13
- 200-day average
- 5.98
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
PRPO Revenue — quarterly 7.02M
PRPO Net income — quarterly -219.00K
PRPO EPS — quarterly -0.12
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | 0.00 | -0.42 | — | — |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | -0.83 | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.00 | -1.46 | — | — |
| Mar 29, 2024 | Dec 1, 2023 | 0.00 | -0.41 | — | — |
| Nov 13, 2023 | Sep 1, 2023 | 0.00 | -1.04 | — | — |
| Aug 11, 2023 | Jun 1, 2023 | 0.00 | -1.80 | — | — |
About Precipio, Inc.
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Website
- precipiodx.com
News
Precipio Announces Q3-2026 Shareholder Update Call 
Precipio (NASDAQ:PRPO) Shares Cross Below 200-Day Moving Average – Here’s Why 
Precipio: Management Dreams Big, Institutions Have A Toe In 
Precipio (NASDAQ:PRPO) Share Price Crosses Below 200 Day Moving Average – What’s Next? 
PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now? 
Analyzing Precipio (NASDAQ:PRPO) and AdaptHealth (NASDAQ:AHCO) 
Precipio Q2 2026 Earnings Call: Complete Transcript 
PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now? 
Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong 
Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript
Your note
Sign in to keep a note on PRPO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANDREWS RONALD ASBURY | Director | Stock Award(Grant) | Oct 14, 2024 | 11,128 |
| COHEN DAVID SETH | Director | Stock Award(Grant) | Oct 14, 2024 | 47,560 |
| COSSMAN JEFFREY M.D. | Director | Stock Award(Grant) | Oct 14, 2024 | 12,312 |
| DANIELI ILAN | Chief Executive Officer | Purchase | Jan 2, 2023 | 57,046 |
| FISHER DOUGLAS CARL M.D. | Director | Stock Award(Grant) | Oct 26, 2023 | 5,572 |
| LAPORTE KATHLEEN D | Director | Stock Award(Grant) | Apr 14, 2024 | 10,071 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 1.95% | 28,912 | 150.38K | Sep 29, 2024 |
| Vanguard Group Inc | 1.19% | 17,645 | 91.78K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.98% | 14,458 | 75.20K | Sep 29, 2024 |
| Wells Fargo & Company | 0.04% | 550 | 2.86K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.04% | 611 | 3.18K | Sep 29, 2024 |
| Citigroup Inc. | 0.03% | 470 | 2.44K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 1.19% | 17,645 | 91.78K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.48% | 7,154 | 37.21K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.21% | 3,097 | 16.11K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.13% | 1,879 | 9.77K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.12% | 1,752 | 9.11K | Oct 30, 2024 |